American International Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-20,327
Closed -$687 3173
2021
Q2
$687 Buy
20,327
+2,438
+14% +$62.1K ﹤0.01% 1739
2021
Q1
$418 Buy
17,889
+47
+0.3% +$1.42K ﹤0.01% 1928
2020
Q4
$514 Sell
17,842
-512
-3% -$12.9K ﹤0.01% 1731
2020
Q3
$372K Buy
18,354
+1,820
+11% +$44.4K ﹤0.01% 1750
2020
Q2
$497K Buy
16,534
+5,344
+48% +$192K ﹤0.01% 1595
2020
Q1
$352K Buy
11,190
+1,511
+16% +$52.5K ﹤0.01% 1602
2019
Q4
$456K Sell
9,679
-82
-0.8% -$2.37K ﹤0.01% 1741
2019
Q3
$63K Sell
9,761
-67
-0.7% -$560 ﹤0.01% 2828
2019
Q2
$121K Sell
9,828
-273
-3% -$3.04K ﹤0.01% 2565
2019
Q1
$137K Buy
10,101
+7,443
+280% +$66.7K ﹤0.01% 2435
2018
Q4
$11K Sell
2,658
-21
-0.8% -$127 ﹤0.01% 3063
2018
Q3
$18K Buy
+2,679
New +$25.5K ﹤0.01% 3141

American International Group's CNST Position: Q3 2021 in Review

American International Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 20,327 shares — an estimated $687 sold.

American International Group first reported a position in CNST in Q3 2018 and held it in 12 quarters. The position peaked at $497K in Q2 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • American International Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • American International Group sold 20,327 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $687.
  • American International Group first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 12 quarters.
  • American International Group's Constellation Pharmaceuticals, Inc. position peaked at $497K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on American International Group's 13F filing for Q3 2021, filed 12 Nov 2021.